U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry RACEMIC
Molecular Formula C14H13NO3
Molecular Weight 243.2579
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ALONIMID

SMILES

O=C1CCC2(CCC(=O)C3=CC=CC=C23)C(=O)N1

InChI

InChIKey=WZAIVXXKOAWTGQ-UHFFFAOYSA-N
InChI=1S/C14H13NO3/c16-11-5-7-14(8-6-12(17)15-13(14)18)10-4-2-1-3-9(10)11/h1-4H,5-8H2,(H,15,17,18)

HIDE SMILES / InChI
Molecular Formula C14H13NO3
Molecular Weight 243.2579
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Description

ALONIMID, a compound which is structurally related to thalidomide, possesses sedative and hypnotic properties.

Approval Year

Unknown
149,124
Substance Class Chemical
Record UNII
14144823D4
Record Status Validated (UNII)
Record Version
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966